ClinicalTrials.Veeva

Menu

Immediate Versus Early Endovenous Ablation In Venous Ulcer

O

Oulu University Hospital

Status

Completed

Conditions

Venous Ulcer

Treatments

Procedure: Endothermal ablation
Procedure: Foam sclerotherapy

Study type

Interventional

Funder types

Other

Identifiers

NCT03795064
268/2018

Details and patient eligibility

About

The study is conducted to assess the effects of immediately started foam sclerotherapy in venous ulcer compared to early intervention.

Full description

Recently EVRA study showed that early endovenous ablation (foam sclerotherapy and/or endothermal ablation) is beneficial for venous ulcer healing. This randomized controlled trial is conducted to assess the effects of immediate foam sclerotherapy in the first visit to vascular outpatient clinic (immediate intervention). Patients in control group will receive foam sclerotherapy at four weeks (early intervention). Endothermal ablation is performed in early setting in both groups when truncal vein anatomy is suitable. The primary outcome for this study is the reduction of venous ulcer area at four weeks.

Enrollment

23 patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Venous ulcer > 1 month
  • Ulcer area > 1cm2
  • Palpable distal pulses / Ankle-brachial index > 0,8 / Toe-brachial index > 70mmhg (at least one criteria must be met)

Exclusion criteria

  • Leg ulcers other than venous etiology
  • Pregnancy
  • General contraindications for foam sclerotherapy
  • Ulcers requiring operation theater revision

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

None (Open label)

23 participants in 2 patient groups

Immediate Intervention
Experimental group
Description:
Patients in this group will be treated with foam sclerotherapy immediately in the first visit to outpatient clinic (immediate intervention).
Treatment:
Procedure: Endothermal ablation
Procedure: Foam sclerotherapy
Early Intervention
Active Comparator group
Description:
Patients in this group will be treated with foam sclerotherapy in the following visit to outpatient clinic at four weeks (early intervention).
Treatment:
Procedure: Endothermal ablation
Procedure: Foam sclerotherapy

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems